JMN Pharmaceutical SA is a Greek company operating in the field of dietary supplements and, more broadly, in the healthcare and wellness sector. Its main activities focus on the development, commercial promotion, and distribution of pharmaceutical and parapharmaceutical products, as well as products for special dietary needs.

JMN Pharmaceutical SA was established in 2008 in Ioannina, Greece. The company's rapid growth led to its expansion into the Industrial Area of Ioannina (B.I.PE.), where its warehouses, covering a total area of 1,200 sq. m., were located until the end of 2016. Subsequently, the warehouses were relocated to Mandra, Attica, where they remain today. The company's accounting department and order processing department remain located in the center of Ioannina.

In 2008, the company's sales department, based in Athens, was added to its operations. The department is responsible for promoting the company's products through both retail and wholesale channels, in Greece and abroad. In 2014, the Research and Development (R&D) Department was established, with the aim of developing and producing products featuring high-quality and innovative characteristics.

Today, JMN Pharmaceutical SA operates both in the Greek and international markets.

Activities

The activities of JMN Pharmaceutical SA in Greece include the import, export, distribution, and trading of pharmaceutical preparations, organically produced products, and dietary supplements. The company holds the exclusive rights for the marketing and distribution of NOW^® Health Group products in Greece and Cyprus. 

According to SPINS^ΤΜ, NOW^® Health Group is one of the leading companies worldwide in the dietary supplements sector. It is an American company engaged in the production of natural products, including dietary supplements, natural foods, sports nutrition products, herbal extracts, essential oils, natural sweeteners, dermocosmetics, and other products. At the same time, the company places particular emphasis on social and environmental responsibility.

In addition to being the exclusive representative of NOW^® Health Group products, JMN Pharmaceutical SA also offers a range of products under its own brand name, NATURA VITA, featuring innovative formulas developed by the company's Research and Development (R&D) Department. These products are marketed both in the Greek market and in international markets, including Italy, among others.

Indicatively, the NATURA VITA product range includes:

• NATURA VITA Dietary Supplements
• NATURA VITA Protein Foods
• NATURA VITA Healthy Foods

Services - Facilities

JMN Pharmaceutical SA remains committed to the values it established from the very beginning of its operations. The services it provides include ensuring the high quality of its products and their effectiveness for consumers who need them.

Detailed product inspections and the determination of scientifically substantiated expiry dates constitute an integral part of the company's operations, contributing to the maintenance of product quality throughout the storage period. The facilities housing the company's warehouses comply with strict storage standards for food and dietary supplements.

JMN Pharmaceutical SA has obtained a quality management system certification in accordance with the ISO 9001 standard, while the certification is reassessed on an annual basis in accordance with the requirements of the applicable ISO 9001 standard.

Objectives

The objectives of JMN Pharmaceutical SA include promoting innovation and establishing cooperation agreements with new companies of high scientific standing. At the same time, a key priority is the continuous renewal of its product portfolio through the development and distribution of modern and innovative products.

In an international economic environment characterized by continuously changing consumer preferences, demand for products that have undergone the necessary quality controls is showing a steady upward trend. Consumers increasingly place particular importance on:

• the quality and reliability of products,
• the variety and innovation of available products, and
• the ease of distributing products between countries.

Despite the economic challenges faced by the Greek market, JMN Pharmaceutical SA continues to expand its product portfolio, aiming to meet the needs of even the most demanding consumers while maintaining its commitment to quality and the consistency that characterize its operations.

Values

One of the fundamental principles of JMN Pharmaceutical SA is consistency and reliability towards its customers and partners. Therefore, the company is committed to ensuring:

• continuous scientific and technological progress,
• the maintenance of high quality standards,
• the development of excellent relationships with both customers and partners, and
• the creation of an excellent and supportive working environment for its employees.

Corporate Social Responsibility

JMN Pharmaceutical SA is a company that meets the necessary standards to be regarded as an example of corporate social responsibility. Financial transparency, compliance with national and international accounting standards, as well as initiatives undertaken by the Sales Department, constitute key elements for adherence to good business practices and compliance with the applicable code of ethics. It is also worth noting that the company's practices and initiatives significantly exceed the minimum requirements established by the legislative framework at both national and international levels.